...
首页> 外文期刊>Drugs & therapy perspectives: for rational drug selection and use >Intravenous medication errors in Selangor, Malaysia: prevalence, contributing factors and potential clinical outcomes
【24h】

Intravenous medication errors in Selangor, Malaysia: prevalence, contributing factors and potential clinical outcomes

机译:雪兰莪,马来西亚的静脉内药物错误:患病率,贡献因素和潜在的临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction Medication errors may have serious implications to both the patient and the healthcare system, and may also compromise patient safety and significantly impact healthcare costs. Therefore, assessing the prevalence and factors associated with intravenous medication errors will significantly improve the quality of care and hospital services. Objective The aim of this study was to determine the prevalence of intravenous medication errors and their potential clinical outcomes. Additionally, this study evaluates the relationship between medication errors and the factors associated with their occurrences.Methods This prospective study was conducted using a direct observation technique and medication record reviews in a secondary hospital in Malaysia. The preparation and administration of intravenous drugs were observed for a total of 213 doses using a checklist supplemented with a review of medication charts.Results Medication administration errors were detected in 85% (181/213) of the doses observed. Overall, 307 errors were identified. After excluding the 39 wrong-time errors, 66.7% (142/213) remained erroneous. More errors were detected during the drug administration stage (62.5%) than in the drug preparation stage (37.5%). Central nervous system drugs recorded the highest error rate at 94.1%. Overall, a total of 43 errors (14.3%) were found to be potentially severe. In a bivariate analysis, the occurrence of errors was significantly associated with nurses' experience and level of education. Conclusion Intravenous preparation and administration errors were highly prevalent in a resource-restricted secondary hospital in Malaysia. Targeted and prompt remedial actions such as training and enforcing existing standard operating procedures to reduce medication errors should be implemented.
机译:引言药物错误可能对患者和医疗保健系统具有严重影响,也可能损害患者安全性并显着影响医疗费用。因此,评估与静脉内药物误差相关的患病率和因素将显着提高护理和医院服务的质量。目的本研究的目的是确定静脉内药物误差及其潜在临床结果的患病率。此外,该研究评估了药物误差与与其出现相关的因素之间的关系。方法使用马来西亚的次级医院直接观察技术和药物记录评论进行了这项前瞻性研究。使用补充药物图表的核对表来观察总共213剂的静脉内药物的制备和施用。结果在观察到的剂量的85%(181/213)中检测到药物治疗误差。总体而言,确定了307个错误。在排除39个错误时间错误后,66.7%(142/213)仍然是错误的。在药物给药阶段(62.5%)检测更多误差,而不是药物制备阶段(37.5%)。中枢神经系统药物记录了94.1%的最高错误率。总的来说,共有43个错误(14.3%)被发现可能是严重的。在双方分析中,误差的发生与护士经验和教育水平有关。结论在马来西亚的资源受限制的次级医院中,静脉注射和给药误差高度普遍。应实施目标和及时的补救措施,如培训和执行现有的标准操作程序以减少药物错误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号